1. Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res. 2002; 33:330–342.
2. Richardson S. Ocular symptoms and complications observed in dengue. Trans Am Ophthalmol Soc. 1933; 31:450–477.
3. Cruz-Villegas V, Berrocal AM, Davis JL. Bilateral choroidal effusions associated with dengue fever. Retina. 2003; 23:576–578.
4. Wen KH, Sheu MM, Chung CB, et al. The ocular fundus findings in dengue fever. Gaoxiong Yi Xue Ke Xue Za Zhi. 1989; 5:24–30.
5. Chia A, Luu CD, Mathur R, et al. Electrophysiological findings in patients with dengue-related maculopathy. Arch Ophthalmol. 2006; 124:1421–1426.
6. Morens DM. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis. 1994; 19:500–512.
7. Su DH, Bacsal K, Chee SP, et al. Prevalence of dengue maculopathy in patients hospitalized for dengue fever. Ophthalmology. 2007; 114:1743–1747.
8. Lim WK, Mathur R, Koh A, et al. Ocular manifestations of dengue fever. Ophthalmology. 2004; 111:2057–2064.
9. Kurane I, Rothman AL, Livingston PG, et al. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl. 1994; 9:59–64.
10. Lei HY, Yeh TM, Liu HS, et al. Immunopathogenesis of dengue virus infection. J Biomed Sci. 2001; 8:377–388.
11. Lin CF, Lei HY, Shiau AL, et al. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol. 2003; 69:82–90.
12. Iida T, Spaide RF, Kantor J. Retinal and choroidal arterial occlusion in Wegener's granulomatosis. Am J Ophthalmol. 2002; 133:151–152.